RTX vs UPB · P/E 36, rev $88.60B vs rev $2.4M
RTX Corporation (RTX) versus Upstream Bio, Inc. (UPB) — a side-by-side from cached financials, not a winner call.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Latest reported UPB revenue for 2024-12-31 was $2.4M. Net income was -$62.8M. Revenue was down 0.4% from 2023-12-31 to 2024-12-31. UPB currently screens at market cap $407.3M.
RTX currently screens at market cap $259.34B and trailing P/E 36.2. UPB currently screens at market cap $407.3M.
Not investment advice. Open the RTX and UPB stock pages for the full models.
Not investment advice.